Matt Sykes
Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
About Matt Sykes
Matt Sykes is recorded as Analyst at Goldman Sachs. Matt Sykes has spoken on 10 earnings calls across 6 companies, most recently for 10x Genomics, Inc. on May 8, 2025. Those appearances were for 10x Genomics, Inc. (TXG), Iqvia Holdings Inc. (IQV), Revvity, Inc. (RVTY), Agilent Technologies, Inc. (A), Guardant Health, Inc. (GH) and 1 other company. The companies whose calls Matt Sykes spoke on are classified in the Healthcare sector.
Matt Sykes on recent calls
“Maybe just focusing on the Xenium consumable pull-through, which was good to see, and you talked about increasing utilization, particularly amongst the larger customers.”
“Ron, just maybe on the margin side, I know you guys have called out in Q4 a 20 basis point potential margin expansion. Looks like as you kind of rearrange the guide, maybe not expecting that.”
“Maybe just For my first question to focus on the signals business, software business, just given it's now becoming, even though it's 8% of total revenues, it's now becoming a pretty important offset this year, just given all the macro headwinds.”
“Maybe just quickly, Amarali, just on Salesforce expansion for Shield, you talked a little bit earlier in the call about maybe being a little bit bigger than what you originally expected.”
“Just back to the commercial changes you made last year, just as we think about the first half of this year, measuring your progress and the success of those commercial changes, I know you said that Xenium would likely be a little bit later.”
Affiliation history
-
Goldman Sachs
Analyst
Source not stated
Current
Company network
Diagnostics & Research · Healthcare
2 appearances
Latest appearance 2025-05-06
View calls and events
Revvity, Inc.
RVTY
Diagnostics & Research · Healthcare
2 appearances
Latest appearance 2025-04-28
View calls and events
Diagnostics & Research · Healthcare
2 appearances
Latest appearance 2022-08-16
View calls and events